Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-05-10 4:37 pm Sale | 13D | Acorda Therapeutics, Inc. ACOR | DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 55,144 4.530% | -35,009 (-38.83%) | Filing History |
| 2023-03-10 4:15 pm Sale | 13D | Acorda Therapeutics, Inc. ACOR | DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 90,154 7.410% | -13,985 (-13.43%) | Filing History |
| 2023-02-14 4:52 pm Sale | 13G | Acorda Therapeutics, Inc. ACOR | CANYON CAPITAL ADVISORS LLC | 0 0.000% | -32,452 (Position Closed) | Filing History |
| 2023-02-13 12:35 pm Purchase | 13G | Acorda Therapeutics, Inc. ACOR | Renaissance Technologies LLC | 43,445 3.570% | 7,737 (+21.67%) | Filing History |
| 2023-01-23 4:30 pm Sale | 13D | Acorda Therapeutics, Inc. ACOR | DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 104,138 8.560% | -16,027 (-13.34%) | Filing History |
| 2022-06-10 4:24 pm Unchanged | 13G | Acorda Therapeutics, Inc. ACOR | SOROS FUND MANAGEMENT LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2022-06-10 4:15 pm Purchase | 13D | Acorda Therapeutics, Inc. ACOR | DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 120,165 9.900% | 120,165 (New Position) | Filing History |
| 2022-02-14 4:56 pm Purchase | 13G | Acorda Therapeutics, Inc. ACOR | CANYON CAPITAL ADVISORS LLC | 32,452 5.790% | 22,633 (+230.52%) | Filing History |
| 2022-02-14 4:33 pm Purchase | 13G | Acorda Therapeutics, Inc. ACOR | Point72 Asset Management, L.P. | 23,214 4.100% | 23,214 (New Position) | Filing History |
| 2022-02-14 10:16 am Unchanged | 13G | Acorda Therapeutics, Inc. ACOR | OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 0 0.000% | 0 (Unchanged) | Filing History |
| 2022-02-11 2:20 pm Purchase | 13G | Acorda Therapeutics, Inc. ACOR | Renaissance Technologies LLC | 35,708 6.380% | 35,708 (New Position) | Filing History |
| 2021-04-28 6:13 pm Sale | 13G | Acorda Therapeutics, Inc. ACOR | CANYON CAPITAL ADVISORS LLC | 9,818 1.820% | -65,179 (-86.91%) | Filing History |
| 2021-02-16 4:16 pm Purchase | 13G | Acorda Therapeutics, Inc. ACOR | CANYON CAPITAL ADVISORS LLC | 74,997 13.910% | 74,997 (New Position) | Filing History |
| 2021-02-16 3:55 pm Sale | 13G | Acorda Therapeutics, Inc. ACOR | DIMENSIONAL FUND ADVISORS LP | 0 0.000% | -24,879 (Position Closed) | Filing History |
| 2021-02-16 3:10 pm Purchase | 13G | Acorda Therapeutics, Inc. ACOR | Point72 Asset Management, L.P. | 45,168 1.900% | 5,985 (+15.28%) | Filing History |
| 2021-02-16 10:41 am Purchase | 13G | Acorda Therapeutics, Inc. ACOR | OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 266,162 9.990% | 266,162 (New Position) | Filing History |
| 2021-02-12 07:46 am Sale | 13G | Acorda Therapeutics, Inc. ACOR | SYMPHONY ASSET MANAGEMENT LLC | 0 0.000% | -38,612 (Position Closed) | Filing History |
| 2021-02-11 10:24 am Purchase | 13G | Acorda Therapeutics, Inc. ACOR | Renaissance Technologies LLC | 204,264 8.520% | 172,121 (+535.47%) | Filing History |
| 2021-02-10 2:49 pm Sale | 13G | Acorda Therapeutics, Inc. ACOR | FEDERATED HERMES INC. FHI | 5,331 1.330% | -26,728 (-83.37%) | Filing History |
| 2021-02-10 12:46 pm Purchase | 13G | Acorda Therapeutics, Inc. ACOR | FEDERATED HERMES INC. FHI | 32,059 8.020% | 32,059 (New Position) | Filing History |